Aprea Therapeutics, Inc. - Common Stock (NQ:APRE)
0.9285
+0.0285
(+3.17%)
Streaming Delayed Price
Updated: 12:51 PM EDT, May 13, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 97,540 |
| Open | 0.9201 |
| Bid (Size) | 0.9170 (300) |
| Ask (Size) | 0.9399 (500) |
| Prev. Close | 0.9000 |
| Today's Range | 0.9101 - 0.9507 |
| 52wk Range | 0.5480 - 2.220 |
| Shares Outstanding | 5,979,292 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Gapping stocks in Monday's session ↗
March 16, 2026
The market is filled with gapping stocks in Wednesday's session. ↗
February 18, 2026
In today's session, these stocks are experiencing unusual volume. ↗
January 30, 2026
What's going on in today's after hours session ↗
January 29, 2026
Frequently Asked Questions
Is Aprea Therapeutics, Inc. - Common Stock publicly traded?
Yes, Aprea Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Aprea Therapeutics, Inc. - Common Stock trade on?
Aprea Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Aprea Therapeutics, Inc. - Common Stock?
The ticker symbol for Aprea Therapeutics, Inc. - Common Stock is APRE on the Nasdaq Stock Market
What is the current price of Aprea Therapeutics, Inc. - Common Stock?
The current price of Aprea Therapeutics, Inc. - Common Stock is 0.9285
When was Aprea Therapeutics, Inc. - Common Stock last traded?
The last trade of Aprea Therapeutics, Inc. - Common Stock was at 05/13/26 12:51 PM ET
What is the market capitalization of Aprea Therapeutics, Inc. - Common Stock?
The market capitalization of Aprea Therapeutics, Inc. - Common Stock is 5.55M
How many shares of Aprea Therapeutics, Inc. - Common Stock are outstanding?
Aprea Therapeutics, Inc. - Common Stock has 6M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.